Results 51 to 60 of about 3,956 (171)
ABSTRACT Background and Aims CMT1H is a rare, autosomal dominant, demyelinating subtype of CMT caused by variants in FBLN5. Symptomatic cranial nerve involvement has never been reported in patients with CMT1H. Case Report We report a 45‐year‐old woman with a history of long‐standing diplopia.
Georgios Koutsis +11 more
wiley +1 more source
Cigarette smoking and treatment outcomes in Graves ophthalmopathy
Background: It is unclear whether smoking affects the course of Graves ophthalmopathy and therapeutic outcomes. Objective: To observe smoking behavior in a randomized study of the effect of radioiodine therapy on ophthalmopathy and in a case series of ...
BARTALENA L. +8 more
core +2 more sources
ABSTRACT Objective This study aimed to identify and report ophthalmic and adnexal diseases found in specimens of the Green sea turtle (Chelonia mydas). Animal Studied and Procedures Thirty‐nine animals stranded on the beaches of the north coast of Bahia, Brazil were submitted to necropsy.
Danielle Nascimento Silva +9 more
wiley +1 more source
Graves' ophthalmopathy: natural history and treatment outcomes
The pathogenesis of Graves' ophthalmopathy has not been yet clarified, and from a therapeutic standpoint Graves' ophthalmopathy remains an enigma.
Bürgi, U +4 more
core +1 more source
BackgroundOphthalmopathy occurring in childhood can easily lead to irreversible visual impairment, and therefore a great deal of clinical and fundamental researches have been conducted in pediatric ophthalmopathy.
Qianfang Jia +7 more
doaj +1 more source
The diagnostic model combining orbital and intracranial MAP‐MRI parameters could significantly optimize diagnostic efficiency of dysthyroid optic neuropathy. Comprehensive MAP‐MRI parameters analysis of the entire visual pathway enables a deeper understanding of disease involvement, provides novel insights into the early accurate diagnosis and ...
Mengsha Zou +7 more
wiley +1 more source
The Influence of Prior Hyperthyroidism on Euthyroid Graves’ Ophthalmopathy [PDF]
Background. To investigate the influence of previous exposure to elevated thyroid hormones in euthyroid Graves' ophthalmopathy. Design. Retrospective, observational case series in university setting Median follow-up of 1 year with ranges of 0,8-7,6 years.
Ilse Mombaerts +5 more
core +1 more source
Thayalini Shanmuganathan,1 Christian Girgis,2 Hooshang Lahooti,1 Bernard Champion,1 Jack R Wall1 1Department of Medicine, Nepean Clinical School, Nepean Hospital, The University of Sydney, Sydney, 2Department of Medicine, Westmead Millennium Institute ...
Shanmuganathan T +4 more
doaj
Teprotumumab for Thyroid Eye Disease: Efficacy and Impact on Orbital Decompression Utilization
Teprotumumab has been proven effective in thyroid eye disease and associated exophthalmos management. Since its FDA approval in 2020, teprotumumab therapy has been a popular choice for managing exophthalmos which has resulted in decreased utilization of orbital decompression surgery, from 36.8% between 2015 and 2020 to 11.1% TED patients between 2020 ...
Nitish Kumar +5 more
wiley +1 more source
Cross-sectional study of thyroid associated orbitopathy in a South African thyroid clinic
Background: Thyroid-associated ophthalmopathy (TAO) is a common and debilitating manifestation of Graves’ disease (GD) associated with poor clinical outcomes including impaired quality-of-life (QoL) and socio-economic status.
Sandra De Vasconcelos +3 more
doaj +1 more source

